Cardiogenic shock: 'going to the mat'--is it needed and does it work?

European Heart Journal
D R Holmes, E J Topol

Abstract

Cardiogenic shock remains a highly lethal event. Fortunately, recent data indicate that some of these high risk patients derive particular survival benefit from aggressive treatment strategies. As yet, there are no randomized trial data, although two trials are currently being performed. Selection bias can affect results, as pointed out by Hockman et al., who found that selection for angiography was associated with improved outcome irrespective of whether revascularization was performed. That not withstanding, in aggregate, the expanding data set indicates that the outcome of cardiogenic shock can be improved with measures to raise blood pressure (therapy improving coronary perfusion), restore persistent flow to the infarct territory (PTCA, stents, or coronary bypass graft surgery) or support the circulation more optimally. The wider spread use of stents may be particularly important. Preliminary data indicate that stenting improves outcome compared to conventional PTCA using the endpoints of TIMI 3 flow, reocclusion, and mortality. Accordingly, stents and other aggressive therapy may be particularly important. These measures will not result in immortality for all patients with cardiogenic shock but do show that the high mortal...Continue Reading

Citations

Mar 10, 2010·Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association·Leigh Anne Wilmot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.